• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.20% Nasdaq Down 0.59%

    Celsion Corp. (CLSN)

    -NasdaqCM
    2.21 Down 0.14(5.93%) 1:39PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.35
    Open:2.41
    Bid:2.21 x 300
    Ask:2.22 x 800
    1y Target Est:7.33
    Beta:1.7
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:2.18 - 2.41
    52wk Range:2.15 - 3.73
    Volume:206,515
    Avg Vol (3m):281,764
    Market Cap:50.86M
    P/E (ttm):N/A
    EPS (ttm):-1.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLSN

    Comparison

    Symbol% ChgMkt Cap
    CLSNDown 5.93%50.86M
    BSDMUp 26.53%N/A
    DCTHUp 1.44%11.30M
    MMSIUp 0.12%944.64M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):94.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.27
    Quarterly EPS Est (Jun-15) :-0.34
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback